04/24/2025 21:37
DNIB.com Reports Internet Has 368.4 Million Domain Name Registrations at the End of the First Quarter of 2025

VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that, according to the latest Domain Name Industry Brief Quarterly Report from DNIB.com, the first quarter of 2025 closed with 368.4 million domain name registrations across all top-level domains (TLDs), an increase of 4.2 million domain name registrations, or 1.1%, compared to the fourth quarter of 2024. Domain name registrations also increased by 6.1 million,...

05/02/2025 13:51
Decent Cybersecurity Joins the Council of Slovak Exporters to Strengthen European Cybersecurity Exports

Decent Cybersecurity, a leading European provider of post-quantum security solutions, announces its membership in the Council of Slovak Exporters (CSE), reinforcing its commitment to expanding advanced cybersecurity exports across global markets. This strategic partnership combines Decent Cybersecurity's expertise in critical infrastructure protection with CSE's established export promotion platform. As a company holding national, EU, and NATO "Secret" level security clearances, Decent Cyberse...

05/07/2025 08:30
Allied Telesis Invests in Sales Enablement Platform With Intangi Eco-System

Today, Allied Telesis, a global leader in connectivity solutions and intelligent networking tools, is significantly enhancing its channel partner ecosystem with the adoption of the Intangi Iris configuration, design, and quoting platform. This strategic investment will enable partners to create Allied Telesis and other best-of-breed multi-vendor solutions tailored to their customers’ need and underscores the company’s commitment to empowering its partners with cutting-edge tools to help drive m...

05/07/2025 09:00
AACR 2025: Brenus Pharma Presents Late-breaking Preclinical Data on its “off-the-shelf” Next-generation Vaccine-based Immunotherapy Candidate, STC-1010, Now Moving to Clinic

Brenus Pharma, a French clinical-stage biotechnology company, presented new preclinical data on its lead immunotherapy candidate, STC-1010, during the Late-Breaking Research: Immunology 3 session at the AACR Annual Meeting 2025, held April 25–30 in Chicago, IL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507231535/en/George Alzeeb, PhD, Innovation Manager at Brenus Pharma, presenting the company’s latest preclinical data on STC...

04/28/2025 13:00
Svante and Mercer International Advance Carbon Capture Project at Alberta Pulp Mill

Svante Technologies Inc. (Svante), a leader in carbon capture and removal technology, today announced that its joint carbon capture and storage project with Mercer International Inc. (Mercer) has advanced to the Front-end Engineering and Design Phase 2 (FEL-2). Also known as Pre-FEED, this phase involves engineering, cost estimation, and risk analysis to evaluate the project's commercial viability. Mercer is a global producer of sustainably sourced forest products, including pulp, lumber, mass ...

05/07/2025 10:00
BeiGene Announces First Quarter 2025 Financial Results and Business Updates

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines, Ltd., today announced financial results and corporate updates from the first quarter 2025. “We delivered another exceptional quarter, achieving our first quarter of GAAP profitability with continued global revenue growth. In the U.S., BRUKINSA remains the leader in new chronic lymphocytic leukemia (CLL) patient starts across all lines of therapy, and for the first time...